Actively Recruiting
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
Led by Nanfang Hospital, Southern Medical University · Updated on 2025-07-04
10000
Participants Needed
1
Research Sites
279 weeks
Total Duration
On this page
Sponsors
N
Nanfang Hospital, Southern Medical University
Lead Sponsor
G
Guangzhou First People's Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this is to learn about the effectiveness and feasibility of a novel AI- assisted Mobile Capsule Gastroscopy (MCG) system for detecting gastric pathologies in elderly and high-risk populations. The main question it aims to answer is: Can MCG effectively detect gastric pathologies, including common gastric diseases, gastric cancer, and precancerous lesions, in elderly and high-risk individuals at community health centers? Participants will: Epidemiological, diagnostic, and post-MCG follow-up data generated during participants' involvement in the gastric pathologies public screening program will be collected.
CONDITIONS
Official Title
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide written informed consent
- Be a participant in the 'Gastric Pathologies Screening Programme for the Elderly and High Risk Groups in Guangzhou Municipality'
- Be a permanent resident of Guangzhou aged 60 years or older who has not had specialized gastric disease screening in the past 3 years
- Or be aged 45 years or older and meet at least one of the following risk factors: history of Helicobacter pylori infection (positive urea breath test), prior diagnosis of chronic atrophic gastritis, gastric ulcer, neoplastic gastric polyps, hypertrophic gastritis, or pernicious anemia
- Family history of gastric cancer in a first-degree relative
- Long-term high-salt diet, history of smoking (20 pack-years or more), or heavy alcohol consumption (100 mL of distilled spirits per day)
You will not qualify if you...
- Considered unsuitable for study participation by the investigator
- Known allergy to medical polymer materials
- Psychiatric disorders interfering with cooperation
- Pregnancy or breastfeeding
- Severe systemic diseases affecting tolerance to examination (such as cardiovascular, respiratory, neurological conditions)
- Inflammatory bowel diseases like Crohn's disease or ulcerative colitis, or gastrointestinal diverticulosis
- Known or suspected gastrointestinal malformations, obstructions, strictures, or fistulas
- Significant difficulty swallowing
- Acute abdominal symptoms such as pain, vomiting, suspected bowel obstruction, or severe constipation
- History of major gastrointestinal surgery (e.g., esophagogastrostomy, gastrojejunostomy)
- Physical weakness preventing body position changes or with concurrent severe illness
- Medically ineligible for abdominal procedures or refusal to undergo them
- Deemed unsuitable for Mobile Capsule Gastroscopy by the investigator
- Refusal to provide informed consent
- Any other condition making participation unsuitable as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China, 510515
Actively Recruiting
Research Team
X
Xiaobei Luo
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here